Galapagos | GLPG - Gross Profit On Sales

Stock Price
25.22
Daily Change
0.58 2.35%
Monthly
-10.38%
Yearly
18.74%
Q2 Forecast
24.95

Galapagos reported EUR-13.57M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
argenx SE USD 1.14B 118.49M Dec/2025
AstraZeneca USD 12.39B 5M Dec/2025
Biogen USD 1.65B 34.6M Dec/2025
Genmab DKK 977M 13M Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Incyte USD 1.39B 118.68M Dec/2025
Merck EUR 2.96B 252M Dec/2025
Neurocrine Biosciences USD 787.9M 7M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 3.19B 621M Dec/2025
Vertex Pharmaceuticals USD 2.72B 62.4M Dec/2025